Literature DB >> 10821947

Measurement of specific IgA in faecal extracts and intestinal lavage fluid for monitoring of mucosal immune responses.

H M Grewal1, T H Karlsen, H Vetvik, C Ahrén, H K Gjessing, H Sommerfelt, B Haneberg.   

Abstract

Currently available methods for the evaluation of antigen-specific immune responses in the intestine, i.e. measurement of IgA in intestinal lavage and antibody secreting cells (ASC) in peripheral blood, are not applicable to large-scale immunogenicity studies or to kinetic studies where repeated sampling is required. Simple and reliable methods need to be developed. Intestinal lavage and faecal samples were collected from 12 mice on days 0, 14, 21, 28 and 35 following initial immunization with four doses of cholera toxin (CT) by the gastric or rectal routes. The concentrations of anti-CT IgA in the faecal extracts showed a high level of correlation with those in the lavage samples (Spearman's correlation coefficient=0.85, P<0. 0001) regardless of the route of CT administration. Moreover, the kinetics of the immune response as reflected in the faecal extracts mirrored those in the lavage samples regardless of immunization route. As compared to gastric immunization, rectal administration of CT yielded higher levels of anti-CT IgA in both intestinal lavage fluids and in faecal extracts. The use of rectal immunization and the measurement of IgA in faecal extracts for monitoring mucosal immune responses may be relevant for the development of effective enteric vaccines.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10821947     DOI: 10.1016/s0022-1759(00)00171-x

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  14 in total

Review 1.  Evaluation of events occurring at mucosal surfaces: techniques used to collect and analyze mucosal secretions and cells.

Authors:  Bruno Guy
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

2.  Purification and functional characterization of mucosal IgA from vaccinated and SIV-infected rhesus macaques.

Authors:  Thomas Musich; Thorsten Demberg; Ian L Morgan; Jacob D Estes; Genoveffa Franchini; Marjorie Robert-Guroff
Journal:  Clin Immunol       Date:  2015-04-01       Impact factor: 3.969

3.  Longitudinal analysis of the prevalence, maintenance, and IgA response to species of the order Bacteroidales in the human gut.

Authors:  Naamah Levy Zitomersky; Michael J Coyne; Laurie E Comstock
Journal:  Infect Immun       Date:  2011-03-14       Impact factor: 3.441

Review 4.  Mechanisms of cellular and humoral immunity through the lens of VLP-based vaccines.

Authors:  Hunter McFall-Boegeman; Xuefei Huang
Journal:  Expert Rev Vaccines       Date:  2022-01-24       Impact factor: 5.217

5.  Short-chain inulin-like fructans reduce endotoxin and bacterial translocations and attenuate development of TNBS-induced colitis in rats.

Authors:  Hiroyuki Ito; Hiroki Tanabe; Hirokazu Kawagishi; Wada Tadashi; Tomono Yasuhiko; Kimio Sugiyama; Shuhachi Kiriyama; Tatsuya Morita
Journal:  Dig Dis Sci       Date:  2008-12-03       Impact factor: 3.199

6.  Differential immunogenicity of vaccinia and HIV-1 components of a human recombinant vaccine in mucosal and blood compartments.

Authors:  Peter A Anton; F Javier Ibarrondo; W John Boscardin; Ying Zhou; Elissa J Schwartz; Hwee L Ng; Mary Ann Hausner; Roger Shih; Julie Elliott; Patricia M Hultin; Lance E Hultin; Charles Price; Marie Fuerst; Amy Adler; Johnson T Wong; Otto O Yang; Beth D Jamieson
Journal:  Vaccine       Date:  2008-06-17       Impact factor: 3.641

7.  Systemic but not mucosal immunity induced by AVA prevents inhalational anthrax.

Authors:  Dennis M Klinman; Debra Currie; Gloria Lee; Vanessa Grippe; Tod Merkel
Journal:  Microbes Infect       Date:  2007-08-10       Impact factor: 2.700

8.  Intestinal and systemic immune responses to an oral cholera toxoid B subunit whole-cell vaccine administered during zinc supplementation.

Authors:  Tom H Karlsen; Halvor Sommerfelt; Skjalg Klomstad; Per Kragh Andersen; Tor A Strand; Rune J Ulvik; Christina Ahrén; Harleen M S Grewal
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

9.  An alphavirus-based adjuvant enhances serum and mucosal antibodies, T cells, and protective immunity to influenza virus in neonatal mice.

Authors:  Syed Muaz Khalil; Daniel R Tonkin; Andrew T Snead; Griffith D Parks; Robert E Johnston; Laura J White
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103

10.  Outer membrane protein A (OmpA) of Shigella flexneri 2a, induces protective immune response in a mouse model.

Authors:  Debasis Pore; Nibedita Mahata; Amit Pal; Manoj K Chakrabarti
Journal:  PLoS One       Date:  2011-07-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.